Brazil vs Tunisia: Treatment success rate for patients treated for MDR-TB
Brazil
60.0%
in 2022
Tunisia
60.0%
in 2021
Brazil rank
120th
Tunisia rank
120th
Treatment success rate for patients treated for MDR-TB over time
- Brazil
- Tunisia
How they compare
Brazil currently reports 60.0% against 60.0% in Tunisia, a difference of 0.0%.
The two have swapped places 2 times across 13 shared years of data; in 2008 it was Tunisia ahead.
Brazil ranks 120th and Tunisia ranks 120th of 163 countries.
Tunisia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brazil | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.5% | 78.5% | 29.0% | Tunisia |
| 2010s | 56.8% | 73.7% | 16.9% | Tunisia |
| 2020s | 53.0% | 74.5% | 21.5% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Brazil or Tunisia?
- Brazil, at 60.0% against 60.0% in Tunisia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Brazil and Tunisia?
- 0.0%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Tunisia?
- 13 years are reported by both, from 2008 to 2021.
- How do Brazil and Tunisia rank globally for treatment success rate for patients treated for mdr-tb?
- Brazil ranks 120th and Tunisia ranks 120th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.